Role of FGF23 in Pediatric Hypercalciuria.

Maria Goretti Moreira Guimarães PenidoMarcelo de Sousa TavaresUri Saggie Alon

Published in: BioMed research international (2017)

Pharmacological treatment of hypercalciuric patients resulted in significantly lower urinary calcium excretion, lower serum FGF23, and elevated TP/GFR and serum phosphate concentration, without significant changes in PTH. Further studies are indicated. This trial is registered with Clinical Registration Number RBR 8W27X5.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
clinical trial
prognostic factors
peritoneal dialysis
randomized controlled trial
patient reported outcomes
phase iii
combination therapy
young adults
patient reported
open label